Liver Diseases  >>  Hepacid (pegargiminase)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hepacid (pegargiminase) / Polaris Pharma
NCT02006030: Ph 2 Trial of ADI PEG 20 Plus Concurrent Transarterial Chemoembolization (TACE) Vs TACE Alone in Patients With Unresectable Hepatocellular Carcinoma

Completed
2
30
RoW
ADI-PEG 20, arginine deiminase formulated with polyethylene glycol, Transarterial chemoembolization, TACE
Polaris Group
Unresectable Hepatocellular Carcinoma
07/16
11/17

Download Options